Walter A (@wazza_233) 's Twitter Profile
Walter A

@wazza_233

Believe, live and đź«€ hard. MD MPH| ACCIMCardio | Chief Resident@ Piedmont Athens AU/UGA |Alum@EmoryRollinsSPH | UGMS |GoDawgs!

ID: 867020766

calendar_today07-10-2012 22:01:18

2,2K Tweet

639 Followers

641 Following

NEJM (@nejm) 's Twitter Profile Photo

Original Article: Empagliflozin after Acute Myocardial Infarction (EMPACT-MI) nej.md/4cEb6EB Editorial: Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment nej.md/3vFF1LK American College of Cardiology #ACC24

Original Article: Empagliflozin after Acute Myocardial Infarction (EMPACT-MI) nej.md/4cEb6EB 

Editorial: Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment nej.md/3vFF1LK 

<a href="/ACCinTouch/">American College of Cardiology</a> #ACC24
Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in NEJM today. In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days. Some thoughts on this ground breaking trial:

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in <a href="/NEJM/">NEJM</a> today.

In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days.

Some thoughts on this ground breaking trial:
Andrew Miller (@apmille1) 's Twitter Profile Photo

I learned something new about a hypertension medication from this soon-to-be CMR. Walter A will be a tremendous cardiology fellow soon. 2 posters and a “fire in the belly” for clinical research. Way to go Dr. Agyeman! American College of Cardiology Quinn Capers, IV

I learned something new about a hypertension medication from this soon-to-be CMR. <a href="/wazza_233/">Walter A</a> will be a tremendous cardiology fellow soon. 2 posters and a “fire in the belly” for clinical research. Way to go Dr. Agyeman! <a href="/ACCinTouch/">American College of Cardiology</a> <a href="/DrQuinnCapers4/">Quinn Capers, IV</a>
Modele Ogunniyi, MD, MPH (@modeldoc) 's Twitter Profile Photo

Congratulations, Alexis Alexis K Okoh, MD Emory Cardiology Fell🫀ws #ACCFIT Emory Cardiology and #ORG co-facilitator on your first author #JACC publication on the #ACC24 #LBCT: #HUDDLE #CVD and #RiskFactors among former #NFL players and family members➡️ bit.ly/3vHzB2S American College of Cardiology Association of Black Cardiologists

Congratulations, Alexis <a href="/OkohMd/">Alexis K Okoh, MD</a> <a href="/emory_heart/">Emory Cardiology Fell🫀ws</a> #ACCFIT <a href="/emoryheart/">Emory Cardiology</a>  and #ORG co-facilitator on your first author #JACC publication on the #ACC24 #LBCT: #HUDDLE #CVD and #RiskFactors among former #NFL players and family members➡️ bit.ly/3vHzB2S
<a href="/ACCinTouch/">American College of Cardiology</a> <a href="/ABCardio1/">Association of Black Cardiologists</a>
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock) nej.md/3xyXU3t Editorial: Mechanical Circulatory Support in Cardiogenic Shock — Persistence and Progress nej.md/4aJTdlK American College of Cardiology #ACC24

Original Article: Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock) nej.md/3xyXU3t 

Editorial: Mechanical Circulatory Support in Cardiogenic Shock — Persistence and Progress nej.md/4aJTdlK 

<a href="/ACCinTouch/">American College of Cardiology</a> #ACC24
NEJM (@nejm) 's Twitter Profile Photo

Presented today at #ACC24: A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT

Presented today at #ACC24: 

A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT
Duk-Woo Park (@dukwoo_park) 's Twitter Profile Photo

A long-waited PREVENT trial is now presented at LBCT-V #ACC2024 🇰🇷From the inception of trial to completion of trial took a decade. ✅1,606 pts with intracoronary imaging-detected “Vulnerable Plaque” randomized 1:1 to (1) Preventive PCI vs (2) OMT alone. ✅Prevent PCI

American College of Cardiology (@accintouch) 's Twitter Profile Photo

Applications Open for ACC's Young Scholars Program! The Young Scholars program is a year-long program providing participants w/ exposure to education, networking, research opportunities & mentorship that is specific to careers in CV medicine. bit.ly/2QRHVJa

Applications Open for ACC's Young Scholars Program!

The Young Scholars program is a year-long program providing participants w/ exposure to education, networking, research opportunities &amp; mentorship that is specific to careers in CV medicine. bit.ly/2QRHVJa
Sammudeen Ibrahim, MD (@sahmibrah) 's Twitter Profile Photo

Today presented another opportunity to not only exhibit excellence but typify discipline and focus. Georgia Chapter Governor, Dr Watkins Clyde Watkins was present to cheers us on. PBerchmann Walter A Basilio Addo. Strong work team. Still VitĂłria Ă© certa! We are PAR! #IM2024

Today presented another opportunity to not only exhibit excellence but typify discipline and focus. Georgia Chapter Governor, Dr Watkins <a href="/ClydeWatkins1/">Clyde Watkins</a> was present to cheers us on. <a href="/BerchmannMD/">PBerchmann</a> <a href="/wazza_233/">Walter A</a> <a href="/basilioaddo/">Basilio Addo</a>. Strong work team. Still VitĂłria Ă© certa! We are PAR! #IM2024
Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

🎉Exciting news alert! Get a sneak peek at the #NYValves2024 Program! 🔍 Explore top sessions led by experts in heart care. Click to discover ➡️ nyvalves2024.crfconferences.com/program-guide STAY TUNED! 🚀 More exhilarating sessions and esteemed faculty will be announced soon, including our highly

🎉Exciting news alert! Get a sneak peek at the #NYValves2024 Program!

🔍 Explore top sessions led by experts in heart care. Click to discover ➡️ nyvalves2024.crfconferences.com/program-guide

STAY TUNED! 🚀 More exhilarating sessions and esteemed faculty will be announced soon, including our highly
Alex Truesdell (@agtruesdell) 's Twitter Profile Photo

1/2 When MCS? “Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice”👉: ajconline.org/article/S0002-……

1/2 When MCS? “Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice”👉: ajconline.org/article/S0002-……
Roger Federer (@rogerfederer) 's Twitter Profile Photo

Vamos, Rafa Nadal!   As you get ready to graduate from tennis, I’ve got a few things to share before I maybe get emotional.   Let’s start with the obvious: you beat me—a lot. More than I managed to beat you. You challenged me in ways no one else could. On clay, it felt like I

Walter A (@wazza_233) 's Twitter Profile Photo

Last weekend was fun! I had the opportunity to present our team's research on 1. Catheter ablation outcomes for AF in HFpEF and 2. Outcomes with HIT in LVAD patients Amazing to gain insights from thought leaders and renowned experts! #AHA #CardiologyResearch #AFib #LVAD

Last weekend was fun! I had the opportunity to present our team's research on 1. Catheter ablation outcomes for AF in HFpEF and 2. Outcomes with HIT in LVAD patients

Amazing to gain insights from thought leaders and renowned experts! #AHA #CardiologyResearch #AFib #LVAD